Lu HF, Hung KS, Hsu YW, et al. Association Study between the FTCDNL1 (FONG) and Susceptibility to Osteoporosis. PLoS One. 2015;10(10):e0140549. doi:10.1371/journal.pone.0140549
Nomura A, Tada H, Teramoto R, et al. Whole exome sequencing combined with integrated variant annotation prediction identifies a causative myosin essential light chain variant in hypertrophic cardiomyopathy. J Cardiol. 2016;67(2):133-9. doi:10.1016/j.jjcc.2015.09.003
Mancuso N, Rohland N, Rand KA, et al. The contribution of rare variation to prostate cancer heritability. Nat Genet. 2016;48(1):30-5. doi:10.1038/ng.3446
Davids MS, Kim HT, Bachireddy P, et al. Ipilimumab for Patients with Relapse after Allogeneic Transplantation. N Engl J Med. 2016;375(2):143-53. doi:10.1056/NEJMoa1601202
Walter S, MejÃa-Guevara I, Estrada K, Liu SY, Glymour M. Association of a Genetic Risk Score With Body Mass Index Across Different Birth Cohorts. JAMA. 2016;316(1):63-9. doi:10.1001/jama.2016.8729
Rioux JD, Stone VA, Daly MJ, et al. Familial eosinophilia maps to the cytokine gene cluster on human chromosomal region 5q31-q33. Am J Hum Genet. 1998;63(4):1086-94. doi:10.1086/302053
Pajukanta P, Cargill M, Viitanen L, et al. Two loci on chromosomes 2 and X for premature coronary heart disease identified in early- and late-settlement populations of Finland. Am J Hum Genet. 2000;67(6):1481-93. doi:10.1086/316902
Lindgren CM, Mahtani MM, Widen E, et al. Genomewide search for type 2 diabetes mellitus susceptibility loci in Finnish families: the Botnia study. Am J Hum Genet. 2002;70(2):509-16. doi:10.1086/338629
Singh D, Febbo PG, Ross K, et al. Gene expression correlates of clinical prostate cancer behavior. Cancer Cell. 2002;1(2):203-9.
Lehto M, Tuomi T, Mahtani MM, et al. Characterization of the MODY3 phenotype. Early-onset diabetes caused by an insulin secretion defect. J Clin Invest. 1997;99(4):582-91. doi:10.1172/JCI119199